Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to Enhance MRI Diagnostic Capabilities in Prostate Cancer

NCT05882253 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT05882253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05882253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to Enhance MRI Diagnostic Capabilities in Prostate Cancer
Lead sponsor
University of California, San Diego
Phase
Not applicable
Overall status
Recruiting
Start date
December 4, 2023
Completion date
April 30, 2028
Enrollment
225 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer